Literature DB >> 11519891

Novel WT1 mutation (C388Y) in a female child with Denys-Drash syndrome.

A Swiatecka-Urban1, M H Mokrzycki, F Kaskel, F Da Silva, E Denamur.   

Abstract

We report the identification of a novel Wilms tumor suppressor gene mutation in a 5-month-old girl who presented with unilateral Wilms tumor (WT) and renal diffuse mesangial sclerosis typical of Denys-Drash syndrome (DDS). The patient did not have ambiguous genitalia and the karyotype (by amniocentesis) was 46, XX. A de novo constitutional heterozygous mutation in WT1 gene exon 9 coding for the third zinc-finger (1163G-->A, C388Y) was identified. This mutation affects a cysteine residue involved in the coordination of the zinc atom, confirming the importance of these residues in the biological function of WT1 protein.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11519891     DOI: 10.1007/s004670100626

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  4 in total

1.  Alteration in DNA-binding affinity of Wilms tumor 1 protein due to WT1 genetic variants associated with steroid - resistant nephrotic syndrome in children.

Authors:  Martin Bezdicka; Filip Kaufman; Ivana Krizova; Alzbeta Dostalkova; Michaela Rumlova; Tomas Seeman; Karel Vondrak; Filip Fencl; Jakub Zieg; Ondrej Soucek
Journal:  Sci Rep       Date:  2022-05-24       Impact factor: 4.996

2.  A novel mutation of WT1 exon 9 in a patient with Denys-Drash syndrome and pyloric stenosis.

Authors:  Min Hu; Jonathon Craig; Neville Howard; Alex Kan; Jeffrey Chaitow; Dianne Little; Stephen I Alexander
Journal:  Pediatr Nephrol       Date:  2004-07-28       Impact factor: 3.714

Review 3.  The role of WT1 in oncogenesis: tumor suppressor or oncogene?

Authors:  David M Loeb; Saraswati Sukumar
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

4.  Evolutive study of children with diffuse mesangial sclerosis.

Authors:  Ana Pilar Nso Roca; Antonia Peña Carrión; Marta Benito Gutiérrez; Carmen García Meseguer; Araceli García Pose; Mercedes Navarro
Journal:  Pediatr Nephrol       Date:  2008-12-10       Impact factor: 3.714

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.